Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Total 13F shares
-
40,440,010
-
Share change
-
+363,352
-
Total reported value
-
$1,024,329,247
-
Put/Call ratio
-
100%
-
Price per share
-
$25.34
-
Number of holders
-
97
-
Value change
-
+$14,285,284
-
Number of buys
-
66
-
Number of sells
-
31
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q2 2019
As of 30 Jun 2019 Apellis Pharmaceuticals, Inc. - Common Stock (APLS) had 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,440,010 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Cormorant Asset Management, LP, HILLHOUSE CAPITAL ADVISORS, LTD., HILLHOUSE CAPITAL MANAGEMENT, LTD., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, ORBIMED ADVISORS LLC, STATE STREET CORP, and VICTORY CAPITAL MANAGEMENT INC.
This table shows 97 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.